Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Selvarajan, S; Lund, LR; Takeuchi, T; Craik, CS; Werb, Z
   A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation
   NATURE CELL BIOLOGY
   
   S. Selvarajan et al., "A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation", NAT CELL BI, 3(3), 2001, pp. 267-275
2. Konduri, SD; Tasiou, A; Chandrasekar, N; Rao, JS
   Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   S.D. Konduri et al., "Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro", INT J ONCOL, 18(1), 2001, pp. 127-131
3. Zhu, H; Liu, W; Shi, W; Xue, YM; Kuai, LT; Ma, Z
   In vitro renaturation of recombinant human pro-urokinase expressed in Escherichia coli
   CHINESE MEDICAL JOURNAL
   
   H. Zhu et al., "In vitro renaturation of recombinant human pro-urokinase expressed in Escherichia coli", CHIN MED J, 114(2), 2001, pp. 186-190
4. Motta, G; Shariat-Madar, Z; Mahdi, F; Sampaio, CAM; Schmaier, AH
   Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix
   THROMBOSIS AND HAEMOSTASIS
   
   G. Motta et al., "Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix", THROMB HAEM, 86(3), 2001, pp. 840-847
5. Poliakov, A; Tkachuk, V; Ovchinnikova, T; Potapenko, N; Bagryantsev, S; Stepanova, V
   Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation
   BIOCHEMICAL JOURNAL
   
   A. Poliakov et al., "Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation", BIOCHEM J, 355, 2001, pp. 639-645
6. Jiao, JW; Yu, MM; Ru, BG
   Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding
   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
   
   J.W. Jiao et al., "Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding", BBA-PROT ST, 1546(2), 2001, pp. 399-405
7. Schenk-Braat, EAM; Morser, J; Rijken, DC
   Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator
   EUROPEAN JOURNAL OF BIOCHEMISTRY
   
   E.A.M. Schenk-Braat et al., "Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator", EUR J BIOCH, 268(21), 2001, pp. 5562-5569
8. Kannemeier, C; Feussner, A; Stohr, HA; Weisse, J; Preissner, KT; Romisch, J
   Factor VII and single-chain plasminogen activator-activating protease - Activation and autoactivation of the proenzyme
   EUROPEAN JOURNAL OF BIOCHEMISTRY
   
   C. Kannemeier et al., "Factor VII and single-chain plasminogen activator-activating protease - Activation and autoactivation of the proenzyme", EUR J BIOCH, 268(13), 2001, pp. 3789-3796
9. Collen, D; Lijnen, HR
   Recent developments in thrombolytic therapy
   FIBRINOLYSIS & PROTEOLYSIS
   
   D. Collen e H.R. Lijnen, "Recent developments in thrombolytic therapy", FIBRINOL PR, 14(2-3), 2000, pp. 66-72
10. Ghosh, S; Ellerbroek, SM; Wu, Y; Stack, MS
    Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences
    FIBRINOLYSIS & PROTEOLYSIS
    
    S. Ghosh et al., "Tumor cell-mediated proteolysis: regulatory mechanisms and functional consequences", FIBRINOL PR, 14(2-3), 2000, pp. 87-97
11. Rijken, DC; Sakharov, DV
    Molecular transport during fibrin clot lysis
    FIBRINOLYSIS & PROTEOLYSIS
    
    D.C. Rijken e D.V. Sakharov, "Molecular transport during fibrin clot lysis", FIBRINOL PR, 14(2-3), 2000, pp. 98-113
12. Vines, DJ; Lee, SW; Dichek, DA; Ellis, V
    Receptor-mediated regulation of plasminogen activator function: Plasminogen activation by two directly membrane-anchored forms of urokinase
    JOURNAL OF PEPTIDE SCIENCE
    
    D.J. Vines et al., "Receptor-mediated regulation of plasminogen activator function: Plasminogen activation by two directly membrane-anchored forms of urokinase", J PEPT SCI, 6(9), 2000, pp. 432-439
13. Lijnen, HR; Collen, D
    Molecular basis of thrombolytic therapy
    JOURNAL OF NUCLEAR CARDIOLOGY
    
    H.R. Lijnen e D. Collen, "Molecular basis of thrombolytic therapy", J NUCL CARD, 7(4), 2000, pp. 373-381
14. Schmaier, AH
    Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions
    CURRENT OPINION IN HEMATOLOGY
    
    A.H. Schmaier, "Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions", CURR OPIN H, 7(5), 2000, pp. 261-265
15. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Liu, JN
    Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion
    PROTEIN EXPRESSION AND PURIFICATION
    
    P. Wang et al., "Glycosylation of prourokinase produced by Pichia pastoris impairs enzymatic activity but not secretion", PROT EX PUR, 20(2), 2000, pp. 179-185
16. Okusa, Y; Ichikura, T; Mochizuki, H; Shinomiya, N
    Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    Y. Okusa et al., "Urokinase type plasminogen activator and its receptor regulates the invasive potential of gastric cancer cell lines", INT J ONCOL, 17(5), 2000, pp. 1001-1005
17. Gurewich, V
    Fibrinolysis: an unfinished agenda
    BLOOD COAGULATION & FIBRINOLYSIS
    
    V. Gurewich, "Fibrinolysis: an unfinished agenda", BL COAG FIB, 11(5), 2000, pp. 401-408
18. Haj-Yehia, A; Nassar, T; Sachais, BS; Kuo, A; Bdeir, K; Al-Mehdi, AB; Mazar, A; Cines, DB; Higazi, AA
    Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo
    FASEB JOURNAL
    
    A. Haj-Yehia et al., "Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo", FASEB J, 14(10), 2000, pp. 1411-1422
19. Aisina, RB; Moukhametova, LI; Firsova, EF; Varfolomeyev, SD
    Prolonged plasma clot lysis induced by acyl-derivatives of urokinase in vitro
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
    
    R.B. Aisina et al., "Prolonged plasma clot lysis induced by acyl-derivatives of urokinase in vitro", APPL BIOC B, 88(1-3), 2000, pp. 137-143
20. Braat, EAM; Collen, A; Jie, AFH; Grimbergen, JM; Rijken, DC
    The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
    
    E.A.M. Braat et al., "The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells", BBA-MOL CEL, 1497(3), 2000, pp. 351-358
21. Wang, P; Zhang, J; Sun, ZY; Chen, YH; Gurewich, V; Liu, JN
    Catalytic and fibrinolytic properties of recombinant urokinase plasminogenactivator from E-coli, mammalian, and yeast cells
    THROMBOSIS RESEARCH
    
    P. Wang et al., "Catalytic and fibrinolytic properties of recombinant urokinase plasminogenactivator from E-coli, mammalian, and yeast cells", THROMB RES, 100(5), 2000, pp. 461-467
22. Lee, SL; Dickson, RB; Lin, CY
    Activation of hepatocyte growth factor and urokinase/plasminogen activatorby matriptase, an epithelial membrane serine protease
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.L. Lee et al., "Activation of hepatocyte growth factor and urokinase/plasminogen activatorby matriptase, an epithelial membrane serine protease", J BIOL CHEM, 275(47), 2000, pp. 36720-36725
23. Bdeir, K; Murciano, JC; Tomaszewski, J; Koniaris, L; Martinez, J; Cines, DB; Muzykantov, VR; Higazi, AAR
    Urokinase mediates fibrinolysis in the pulmonary microvasculature
    BLOOD
    
    K. Bdeir et al., "Urokinase mediates fibrinolysis in the pulmonary microvasculature", BLOOD, 96(5), 2000, pp. 1820-1826
24. Macchione, E; Epifano, O; Stefanini, M; Belin, D; Canipari, R
    Urokinase redistribution from the secreted to the cell-bound fraction in granulosa cells of rat preovulatory follicles
    BIOLOGY OF REPRODUCTION
    
    E. Macchione et al., "Urokinase redistribution from the secreted to the cell-bound fraction in granulosa cells of rat preovulatory follicles", BIOL REPROD, 62(4), 2000, pp. 895-903
25. Ouriel, K; Kandarpa, K; Schuerr, DM; Hultquist, M; Hodkinson, G; Wallin, B
    Prourokinase versus urokinase for recanalization of peripheral occlusions,safety and efficacy: The PURPOSE trial
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    
    K. Ouriel et al., "Prourokinase versus urokinase for recanalization of peripheral occlusions,safety and efficacy: The PURPOSE trial", J VAS INT R, 10(8), 1999, pp. 1083-1091
26. Kang, HM; Choi, KS; Kassam, G; Fitzpatrick, SL; Kwon, M; Waisman, DM
    Role of annexin II tetramer in plasminogen activation
    TRENDS IN CARDIOVASCULAR MEDICINE
    
    H.M. Kang et al., "Role of annexin II tetramer in plasminogen activation", TREND CARD, 9(3-4), 1999, pp. 92-102
27. Mohanam, S; Go, Y; Sawaya, R; Venkaiah, B; Mohan, PM; Kouraklis, GP; Gokaslan, ZL; Lagos, GK; Rao, JS
    Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    S. Mohanam et al., "Elevated levels of urokinase-type plasminogen activator and its receptor during tumor growth in vivo", INT J ONCOL, 14(1), 1999, pp. 169-174
28. Zhu, FX; He, FC
    Progress in study of structure-function relationship and protein engineering of plasminogen activators
    CHINESE SCIENCE BULLETIN
    
    F.X. Zhu e F.C. He, "Progress in study of structure-function relationship and protein engineering of plasminogen activators", CHIN SCI B, 44(4), 1999, pp. 289-294
29. Michels, HR; Hoffman, JJML; Bar, FWHM
    Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: Comparison of infusion, single-bolus, and split-bolus administration
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    H.R. Michels et al., "Pharmacokinetics and hemostatic effects of saruplase in patients with acute myocardial infarction: Comparison of infusion, single-bolus, and split-bolus administration", J THROMB TH, 8(3), 1999, pp. 213-221
30. Maksimenko, AV; Tischenko, EG
    New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    A.V. Maksimenko e E.G. Tischenko, "New thrombolytic strategy: Bolus administration of tPA and urokinase-fibrinogen conjugate", J THROMB TH, 7(3), 1999, pp. 307-312
31. Jiang, L; Yang, YH; Chatterjee, S; Seidel, B; Wolf, G; Yang, SL
    The expression of proUK in Escherichia coli: The vgb promoter replaces IPTG and coexpression of argU compensates for rare codons in a hypoxic induction model
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    
    L. Jiang et al., "The expression of proUK in Escherichia coli: The vgb promoter replaces IPTG and coexpression of argU compensates for rare codons in a hypoxic induction model", BIOS BIOT B, 63(12), 1999, pp. 2097-2101
32. Schousboe, I; Feddersen, K; Rojkjaer, R
    Factor XIIa is a kinetically favorable plasminogen activator
    THROMBOSIS AND HAEMOSTASIS
    
    I. Schousboe et al., "Factor XIIa is a kinetically favorable plasminogen activator", THROMB HAEM, 82(3), 1999, pp. 1041-1046
33. Weitz, JI; Stewart, RJ; Fredenburgh, JC
    Mechanism of action of plasminogen activators
    THROMBOSIS AND HAEMOSTASIS
    
    J.I. Weitz et al., "Mechanism of action of plasminogen activators", THROMB HAEM, 82(2), 1999, pp. 974-982
34. Monvoisin, A; Neaud, V; De Ledinghen, V; Dubuisson, L; Balabaud, C; Bioulac-Sage, P; Desmouliere, A; Rosenbaum, J
    Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase
    JOURNAL OF HEPATOLOGY
    
    A. Monvoisin et al., "Direct evidence that hepatocyte growth factor-induced invasion of hepatocellular carcinoma cells is mediated by urokinase", J HEPATOL, 30(3), 1999, pp. 511-518
35. Rojkjaer, R; Schmaier, AH
    Activation of the plasma kallikrein/kinin system on endothelial cell membranes
    IMMUNOPHARMACOLOGY
    
    R. Rojkjaer e A.H. Schmaier, "Activation of the plasma kallikrein/kinin system on endothelial cell membranes", IMMUNOPHARM, 43(2-3), 1999, pp. 109-114
36. Ogura, N; Nagura, H; Abiko, Y
    Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide
    JOURNAL OF PERIODONTOLOGY
    
    N. Ogura et al., "Increase of urokinase-type plasminogen activator receptor expression in human gingival fibroblasts by Porphyromonas gingivalis lipopolysaccharide", J PERIODONT, 70(4), 1999, pp. 402-408
37. Braat, EAM; Levi, M; Bos, R; Haverkate, F; Lassen, MR; de Maat, MPM; Rijken, DC
    Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE
    
    E.A.M. Braat et al., "Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects", J LA CL MED, 134(2), 1999, pp. 161-167
38. Longstaff, C; Merton, RE; Fabregas, P; Felez, J
    Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)
    BLOOD
    
    C. Longstaff et al., "Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87)", BLOOD, 93(11), 1999, pp. 3839-3846
39. VANDERKAADEN ME; RIJKEN DC; VANBERKEL TJC; KUIPER J
    PLASMA-CLEARANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    FIBRINOLYSIS & PROTEOLYSIS
    
    M.E. Vanderkaaden et al., "PLASMA-CLEARANCE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR", FIBRINOLYSIS & PROTEOLYSIS, 12(4), 1998, pp. 251-258
40. GULBA DC; BODE C; RUNGE MS; HUBER K
    THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW
    FIBRINOLYSIS & PROTEOLYSIS
    
    D.C. Gulba et al., "THROMBOLYTIC AGENTS - AN UPDATED OVERVIEW", FIBRINOLYSIS & PROTEOLYSIS, 12, 1998, pp. 39-58
41. WILHELM S; SCHMITT M; PARKINSON J; KUHN W; GRAEFF H; WILHELM OG
    THROMBOMODULIN, A RECEPTOR FOR THE SERINE-PROTEASE THROMBIN, IS DECREASED IN PRIMARY TUMORS AND METASTASES BUT INCREASED IN ASCITIC FLUIDS OF PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-IIIC
    International journal of oncology
    
    S. Wilhelm et al., "THROMBOMODULIN, A RECEPTOR FOR THE SERINE-PROTEASE THROMBIN, IS DECREASED IN PRIMARY TUMORS AND METASTASES BUT INCREASED IN ASCITIC FLUIDS OF PATIENTS WITH ADVANCED OVARIAN-CANCER FIGO-IIIC", International journal of oncology, 13(4), 1998, pp. 645-651
42. Tsurutani, T; Orita, T; Kitahara, T
    Thrombolytic therapy by pro-Urokinase combined with tissue plasminogen activator in an acute internal carotid occlusion
    JOURNAL OF CLINICAL NEUROSCIENCE
    
    T. Tsurutani et al., "Thrombolytic therapy by pro-Urokinase combined with tissue plasminogen activator in an acute internal carotid occlusion", J CL NEUROS, 5(3), 1998, pp. 329-331
43. BRAAT EAM; LOS P; RIJKEN DC
    THE INACTIVATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORBY THROMBIN IN A PLASMA MILIEU - EFFECT OF THROMBOMODULIN
    Blood coagulation & fibrinolysis
    
    E.A.M. Braat et al., "THE INACTIVATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORBY THROMBIN IN A PLASMA MILIEU - EFFECT OF THROMBOMODULIN", Blood coagulation & fibrinolysis, 9(5), 1998, pp. 419-427
44. GUNZLER WA
    SARUPLASE - BACKGROUND AND BIOCHEMISTRY
    Reviews in contemporary pharmacotherapy
    
    W.A. Gunzler, "SARUPLASE - BACKGROUND AND BIOCHEMISTRY", Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 355-362
45. MICHELS HR
    THE IMPORTANCE OF SARUPLASE IN THE CONTEXT OF OTHER THROMBOLYTIC MEDICATIONS
    Reviews in contemporary pharmacotherapy
    
    H.R. Michels, "THE IMPORTANCE OF SARUPLASE IN THE CONTEXT OF OTHER THROMBOLYTIC MEDICATIONS", Reviews in contemporary pharmacotherapy, 9(6), 1998, pp. 403-409
46. MUSTJOKI S; TAPIOVAARA H; SIREN V; VAHERI A
    INTERFERONS AND RETINOIDS ENHANCE AND DEXAMETHASONE SUPPRESSES UROKINASE-MEDIATED PLASMINOGEN ACTIVATION IN PROMYELOCYTIC LEUKEMIA-CELLS
    Leukemia
    
    S. Mustjoki et al., "INTERFERONS AND RETINOIDS ENHANCE AND DEXAMETHASONE SUPPRESSES UROKINASE-MEDIATED PLASMINOGEN ACTIVATION IN PROMYELOCYTIC LEUKEMIA-CELLS", Leukemia, 12(2), 1998, pp. 164-174
47. BOUMA BN; VONDEMBORNE PAK; MEIJERS JCM
    FACTOR-XI AND PROTECTION OF THE FIBRIN CLOT AGAINST LYSIS - A ROLE FOR THE INTRINSIC PATHWAY OF COAGULATION IN FIBRINOLYSIS
    Thrombosis and haemostasis
    
    B.N. Bouma et al., "FACTOR-XI AND PROTECTION OF THE FIBRIN CLOT AGAINST LYSIS - A ROLE FOR THE INTRINSIC PATHWAY OF COAGULATION IN FIBRINOLYSIS", Thrombosis and haemostasis, 80(1), 1998, pp. 24-27
48. KIENAST J; PADRO T; STEINS M; LI CX; SCHMID KW; HAMMEL D; SCHELD HH; VANDELOO JCW
    RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES
    Thrombosis and haemostasis
    
    J. Kienast et al., "RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES", Thrombosis and haemostasis, 79(3), 1998, pp. 579-586
49. INOUE T; HASUMI K; SUGIMOTO M; ENDO A
    ENHANCEMENT OF FIBRINOLYSIS BY PLACTINS - STRUCTURE-ACTIVITY RELATIONSHIP AND EFFECTS IN HUMAN U937 CELLS AND IN MICE
    Thrombosis and haemostasis
    
    T. Inoue et al., "ENHANCEMENT OF FIBRINOLYSIS BY PLACTINS - STRUCTURE-ACTIVITY RELATIONSHIP AND EFFECTS IN HUMAN U937 CELLS AND IN MICE", Thrombosis and haemostasis, 79(3), 1998, pp. 591-596
50. Festuccia, C; Dolo, V; Guerra, F; Violini, S; Muzi, P; Pavan, A; Bologna, M
    Plasminogen activator system modulates invasive capacity and proliferationin prostatic tumor cells
    CLINICAL & EXPERIMENTAL METASTASIS
    
    C. Festuccia et al., "Plasminogen activator system modulates invasive capacity and proliferationin prostatic tumor cells", CLIN EXP M, 16(6), 1998, pp. 513-528
51. MAKSIMENKO AV
    COMBINED THROMBOLYSIS BY PHARMACOKINETICA LLY DIFFERENT PLASMINOGEN ACTIVATORS
    Bioorganiceskaa himia
    
    A.V. Maksimenko, "COMBINED THROMBOLYSIS BY PHARMACOKINETICA LLY DIFFERENT PLASMINOGEN ACTIVATORS", Bioorganiceskaa himia, 24(5), 1998, pp. 376-380
52. COLLSANGRONA E; AROCHAPINANGO CL
    FIBRINOLYTIC ACTION ON FRESH HUMAN CLOTS OF WHOLE-BODY EXTRACTS AND 2SEMIPURIFIED FRACTIONS FROM LONOMIA-ACHELOUS CATERPILLAR
    Brazilian journal of medical and biological research
    
    E. Collsangrona e C.L. Arochapinango, "FIBRINOLYTIC ACTION ON FRESH HUMAN CLOTS OF WHOLE-BODY EXTRACTS AND 2SEMIPURIFIED FRACTIONS FROM LONOMIA-ACHELOUS CATERPILLAR", Brazilian journal of medical and biological research, 31(6), 1998, pp. 779-784
53. MALONE MD; BARBER L; COMEROTA AJ
    CLINICAL-APPLICATIONS OF THROMBOLYTIC THERAPY FOR ARTERIAL AND GRAFT OCCLUSION
    The Surgical clinics of North America
    
    M.D. Malone et al., "CLINICAL-APPLICATIONS OF THROMBOLYTIC THERAPY FOR ARTERIAL AND GRAFT OCCLUSION", The Surgical clinics of North America, 78(4), 1998, pp. 647
54. FRANCO P; MASSA O; GARCIAROCHA R; CHIARADONNA F; IACCARINO C; CORREAS I; MENDEZ E; AVILA J; BLASI F; STOPPELLI MP
    PROTEIN-KINASE C-DEPENDENT IN-VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST
    The Journal of biological chemistry
    
    P. Franco et al., "PROTEIN-KINASE C-DEPENDENT IN-VIVO PHOSPHORYLATION OF PROUROKINASE LEADS TO THE FORMATION OF A RECEPTOR COMPETITIVE ANTAGONIST", The Journal of biological chemistry, 273(42), 1998, pp. 27734-27740
55. ALEXANDER DS; SIPLEY JD; QUIGLEY JP
    AUTOACTIVATION OF AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - A NOVEL MODE OF INITIATION OF THE UPA PLASMIN CASCADE/
    The Journal of biological chemistry
    
    D.S. Alexander et al., "AUTOACTIVATION OF AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) - A NOVEL MODE OF INITIATION OF THE UPA PLASMIN CASCADE/", The Journal of biological chemistry, 273(13), 1998, pp. 7457-7461
56. FESTUCCIA C; GUERRA F; DASCENZO S; GIUNCIUGLIO D; ALBINI A; BOLOGNA M
    IN-VITRO REGULATION OF PERICELLULAR PROTEOLYSIS IN PROSTATIC TUMOR-CELLS TREATED WITH BOMBESIN
    International journal of cancer
    
    C. Festuccia et al., "IN-VITRO REGULATION OF PERICELLULAR PROTEOLYSIS IN PROSTATIC TUMOR-CELLS TREATED WITH BOMBESIN", International journal of cancer, 75(3), 1998, pp. 418-431
57. BRUNNER G; REIMBOLD K; MEISSAUER A; SCHIRRMACHER V; ERKELL LJ
    SULFATED GLYCOSAMINOGLYCANS ENHANCE TUMOR-CELL INVASION IN-VITRO BY STIMULATING PLASMINOGEN ACTIVATION
    Experimental cell research
    
    G. Brunner et al., "SULFATED GLYCOSAMINOGLYCANS ENHANCE TUMOR-CELL INVASION IN-VITRO BY STIMULATING PLASMINOGEN ACTIVATION", Experimental cell research, 239(2), 1998, pp. 301-310
58. ODA M; SHIRAISHI A; HASEGAWA M
    ANALYSIS OF THE TERNARY COMPLEX-FORMATION OF HUMAN UROKINASE WITH THESEPARATED 2 DOMAINS OF ITS RECEPTOR
    European journal of biochemistry
    
    M. Oda et al., "ANALYSIS OF THE TERNARY COMPLEX-FORMATION OF HUMAN UROKINASE WITH THESEPARATED 2 DOMAINS OF ITS RECEPTOR", European journal of biochemistry, 256(2), 1998, pp. 411-418
59. Cejkova, J
    The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits
    DOCUMENTA OPHTHALMOLOGICA
    
    J. Cejkova, "The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits", DOC OPHTHAL, 95(2), 1998, pp. 165-179
60. HIGAZI AA; BDEIR K; HISS E; ARAD S; KUO A; BARGHOUTI I; CINES DB
    LYSIS OF PLASMA CLOTS BY UROKINASE-SOLUBLE UROKINASE RECEPTOR COMPLEXES
    Blood
    
    A.A. Higazi et al., "LYSIS OF PLASMA CLOTS BY UROKINASE-SOLUBLE UROKINASE RECEPTOR COMPLEXES", Blood, 92(6), 1998, pp. 2075-2083
61. SUN ZY; LIU BF; CHEN YH; GUREWICH V; ZHU DX; LIU JN
    ANALYSIS OF THE FORCES WHICH STABILIZE THE ACTIVE CONFORMATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    Biochemistry
    
    Z.Y. Sun et al., "ANALYSIS OF THE FORCES WHICH STABILIZE THE ACTIVE CONFORMATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR", Biochemistry, 37(9), 1998, pp. 2935-2940
62. UGWU F; VANHOEF B; BINI A; COLLEN D; LIJNEN HR
    PROTEOLYTIC CLEAVAGE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY STROMELYSIN-1 (MMP-3)
    Biochemistry
    
    F. Ugwu et al., "PROTEOLYTIC CLEAVAGE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BY STROMELYSIN-1 (MMP-3)", Biochemistry, 37(20), 1998, pp. 7231-7236
63. KREKORA K; VITACOLONNA E; DICASTELNUOVO A; DORAZIO A; DELUCIA D; DOOIJEWAARD G; CAPANI F; DONATI MB; IACOVIELLO L
    DECREASE IN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    Fibrinolysis & proteolysis
    
    K. Krekora et al., "DECREASE IN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LEVELS IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS", Fibrinolysis & proteolysis, 11(4), 1997, pp. 215-219
64. TEBBE U; GUNZLER WA; HOPKINS GR; GRYMBOWSKI T; BARTH H
    THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA
    Fibrinolysis & proteolysis
    
    U. Tebbe et al., "THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL-INFARCTION WITH SARUPLASE, ASINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) FROM RECOMBINANT BACTERIA", Fibrinolysis & proteolysis, 11, 1997, pp. 45-54
65. VANGRIENSVEN JMT; KOSTER RW; HOPKINS GR; BEIER H; GUNZLER WA; KROON R; SCHOEMAKER RC; COHEN AF
    EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    Thrombosis and haemostasis
    
    J.M.T. Vangriensven et al., "EFFECT OF CHANGES IN LIVER BLOOD-FLOW ON THE PHARMACOKINETICS OF SARUPLASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION", Thrombosis and haemostasis, 78(3), 1997, pp. 1015-1020
66. VANDERKAADEN ME; RIJKEN DC; KRUIJT JK; VANBERKEL TJC; KUIPER J
    THE ROLE OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) IN THE PLASMA-CLEARANCE AND LIVER UPTAKE OF RECOMBINANT SINGLE-CHAINUROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN RATS
    Thrombosis and haemostasis
    
    M.E. Vanderkaaden et al., "THE ROLE OF THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) IN THE PLASMA-CLEARANCE AND LIVER UPTAKE OF RECOMBINANT SINGLE-CHAINUROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN RATS", Thrombosis and haemostasis, 77(4), 1997, pp. 710-717
67. NYKJAER A; CONESE M; CHRISTENSEN EI; OLSON D; CREMONA O; GLIEMANN J; BLASI F
    RECYCLING OF THE UROKINASE RECEPTOR UPON INTERNALIZATION OF THE UPA-SERPIN COMPLEXES
    EMBO journal
    
    A. Nykjaer et al., "RECYCLING OF THE UROKINASE RECEPTOR UPON INTERNALIZATION OF THE UPA-SERPIN COMPLEXES", EMBO journal, 16(10), 1997, pp. 2610-2620
68. SUN ZY; JIANG YP; MA Z; WU H; LIU BF; XU YM; TANG W; CHEN YH; LI CZ; ZHU DX; GUREWICH V; LIU JN
    IDENTIFICATION OF A FLEXIBLE LOOP REGION-(297-313) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, WHICH HELPS DETERMINE ITS CATALYTIC ACTIVITY
    The Journal of biological chemistry
    
    Z.Y. Sun et al., "IDENTIFICATION OF A FLEXIBLE LOOP REGION-(297-313) OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, WHICH HELPS DETERMINE ITS CATALYTIC ACTIVITY", The Journal of biological chemistry, 272(38), 1997, pp. 23818-23823
69. OKUMURA Y; SATO H; SEIKI M; KIDO H
    PROTEOLYTIC ACTIVATION OF THE PRECURSOR OF MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE BY HUMAN PLASMIN - A POSSIBLE CELL-SURFACE ACTIVATOR
    FEBS letters
    
    Y. Okumura et al., "PROTEOLYTIC ACTIVATION OF THE PRECURSOR OF MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE BY HUMAN PLASMIN - A POSSIBLE CELL-SURFACE ACTIVATOR", FEBS letters, 402(2-3), 1997, pp. 181-184
70. LENICH C; LIU JN; GUREWICH V
    THROMBIN STIMULATION OF PLATELETS INDUCES PLASMINOGEN ACTIVATION MEDIATED BY ENDOGENOUS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    Blood
    
    C. Lenich et al., "THROMBIN STIMULATION OF PLATELETS INDUCES PLASMINOGEN ACTIVATION MEDIATED BY ENDOGENOUS UROKINASE-TYPE PLASMINOGEN-ACTIVATOR", Blood, 90(9), 1997, pp. 3579-3586
71. LIN YZ; HARRIS RB; YAN WY; MCCRAE KR; ZHANG H; COLMAN RW
    HIGH-MOLECULAR-WEIGHT KININOGEN PEPTIDES INHIBIT THE FORMATION OF KALLIKREIN ON ENDOTHELIAL-CELL SURFACES AND SUBSEQUENT UROKINASE-DEPENDENT PLASMIN FORMATION
    Blood
    
    Y.Z. Lin et al., "HIGH-MOLECULAR-WEIGHT KININOGEN PEPTIDES INHIBIT THE FORMATION OF KALLIKREIN ON ENDOTHELIAL-CELL SURFACES AND SUBSEQUENT UROKINASE-DEPENDENT PLASMIN FORMATION", Blood, 90(2), 1997, pp. 690-697
72. ALEXANDER DS; AIMES RT; QUIGLEY JP
    WHAT STRUCTURE AND FUNCTION OF AVIAN PLASMINOGEN-ACTIVATOR AND MATRIXMETALLOPROTEINASE-2 REVEAL ABOUT THEIR COUNTERPART MAMMALIAN ENZYMES,THEIR REGULATION AND THEIR ROLE IN TUMOR INVASION
    Enzyme & protein
    
    D.S. Alexander et al., "WHAT STRUCTURE AND FUNCTION OF AVIAN PLASMINOGEN-ACTIVATOR AND MATRIXMETALLOPROTEINASE-2 REVEAL ABOUT THEIR COUNTERPART MAMMALIAN ENZYMES,THEIR REGULATION AND THEIR ROLE IN TUMOR INVASION", Enzyme & protein, 49(1-3), 1996, pp. 38-58
73. MICHELS HR; HOFFMANN JJML; WINDELER J; HOPKINS GR
    HEMOSTATIC CHANGES AFTER THROMBOLYTIC THERAPY WITH SARUPLASE (UNGLYCOSYLATED SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR) AND UROKINASE (2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR)
    Blood coagulation & fibrinolysis
    
    H.R. Michels et al., "HEMOSTATIC CHANGES AFTER THROMBOLYTIC THERAPY WITH SARUPLASE (UNGLYCOSYLATED SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR) AND UROKINASE (2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR)", Blood coagulation & fibrinolysis, 7(8), 1996, pp. 766-771
74. GULBA DC; BODE C; RUNGE MS; HUBER K
    THROMBOLYTIC AGENTS - AN OVERVIEW
    Annals of hematology
    
    D.C. Gulba et al., "THROMBOLYTIC AGENTS - AN OVERVIEW", Annals of hematology, 73, 1996, pp. 9-27
75. GROSSMANN R; EBELL JB; MISOPH M; SCHWENDER S; NEUKAM K; HICKETHIER T; ELERT O; KELLER F
    CHANGES IN COAGULATION AND FIBRINOLYTIC PARAMETERS CAUSED BY EXTRACORPOREAL-CIRCULATION
    Heart and vessels
    
    R. Grossmann et al., "CHANGES IN COAGULATION AND FIBRINOLYTIC PARAMETERS CAUSED BY EXTRACORPOREAL-CIRCULATION", Heart and vessels, 11(6), 1996, pp. 310-317
76. TSUJIKAWA M; OKABAYASHI K; MORITA M; TANABE T
    SECRETION OF A VARIANT OF HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR WITHOUT AN N-GLYCOSYLATION SITE IN THE METHYLOTROPHIC YEAST, PICHIA-PASTORIS AND CHARACTERIZATION OF THE SECRETED PRODUCT
    Yeast
    
    M. Tsujikawa et al., "SECRETION OF A VARIANT OF HUMAN SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR WITHOUT AN N-GLYCOSYLATION SITE IN THE METHYLOTROPHIC YEAST, PICHIA-PASTORIS AND CHARACTERIZATION OF THE SECRETED PRODUCT", Yeast, 12(6), 1996, pp. 541-553
77. FOX D; OURIEL K; GREEN RM; STOUGHTON J; RIGGS P; CIMINO C
    THROMBOLYSIS WITH PROUROKINASE VERSUS UROKINASE - AN IN-VITRO COMPARISON
    Journal of vascular surgery
    
    D. Fox et al., "THROMBOLYSIS WITH PROUROKINASE VERSUS UROKINASE - AN IN-VITRO COMPARISON", Journal of vascular surgery, 23(4), 1996, pp. 657-666
78. LENGYEL E; GUM R; STEPP E; JUAREZ J; WANG H; BOYD D
    REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION BY AN ERK1-DEPENDENT SIGNALING PATHWAY IN A SQUAMOUS-CELL CARCINOMA CELL-LINE
    Journal of cellular biochemistry
    
    E. Lengyel et al., "REGULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION BY AN ERK1-DEPENDENT SIGNALING PATHWAY IN A SQUAMOUS-CELL CARCINOMA CELL-LINE", Journal of cellular biochemistry, 61(3), 1996, pp. 430-443
79. BRAAT EAM; NAULAND U; DOOIJEWAARD G; RIJKEN DC
    A SENSITIVE BIOIMMUNOASSAY FOR THROMBIN-CLEAVED 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN-BODY FLUIDS
    Thrombosis and haemostasis
    
    E.A.M. Braat et al., "A SENSITIVE BIOIMMUNOASSAY FOR THROMBIN-CLEAVED 2-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN-BODY FLUIDS", Thrombosis and haemostasis, 75(6), 1996, pp. 908-914
80. TKACHUK V; STEPANOVA V; LITTLE PJ; BOBIK A
    REGULATION AND ROLE OF UROKINASE PLASMINOGEN-ACTIVATOR IN VASCULAR REMODELING
    Clinical and experimental pharmacology and physiology
    
    V. Tkachuk et al., "REGULATION AND ROLE OF UROKINASE PLASMINOGEN-ACTIVATOR IN VASCULAR REMODELING", Clinical and experimental pharmacology and physiology, 23(9), 1996, pp. 759-765
81. STRINGER KA
    BIOCHEMICAL AND PHARMACOLOGICAL COMPARISON OF THROMBOLYTIC AGENTS
    Pharmacotherapy
    
    K.A. Stringer, "BIOCHEMICAL AND PHARMACOLOGICAL COMPARISON OF THROMBOLYTIC AGENTS", Pharmacotherapy, 16(5), 1996, pp. 119-126
82. ALLAN EH; MARTIN TJ
    RECEPTOR-MEDIATED EFFECT OF THROMBIN ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS IN RAT OSTEOBLAST-LIKE CELLS
    Fibrinolysis
    
    E.H. Allan e T.J. Martin, "RECEPTOR-MEDIATED EFFECT OF THROMBIN ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS IN RAT OSTEOBLAST-LIKE CELLS", Fibrinolysis, 10(5-6), 1996, pp. 285-293
83. RESNATI M; GUTTINGER M; VALCAMONICA S; SIDENIUS N; BLASI F; FAZIOLI F
    PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT
    EMBO journal
    
    M. Resnati et al., "PROTEOLYTIC CLEAVAGE OF THE UROKINASE RECEPTOR SUBSTITUTES FOR THE AGONIST-INDUCED CHEMOTACTIC EFFECT", EMBO journal, 15(7), 1996, pp. 1572-1582
84. YOSHIMOTO M; USHIYAMA Y; SAKAI M; TAMAKI S; HARA H; TAKAHASHI K; SAWASAKI Y; HANADA K
    CHARACTERIZATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORWITH A NOVEL AMINO-ACID SUBSTITUTION IN THE KRINGLE STRUCTURE
    Biochimica et biophysica acta. Protein structure and molecular enzymology
    
    M. Yoshimoto et al., "CHARACTERIZATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATORWITH A NOVEL AMINO-ACID SUBSTITUTION IN THE KRINGLE STRUCTURE", Biochimica et biophysica acta. Protein structure and molecular enzymology, 1293(1), 1996, pp. 83-89
85. HIGAZI AAR; CINES D
    REGULATION OF SINGLE-CHAIN UROKINASE BY SMALL PEPTIDES
    Thrombosis research
    
    A.A.R. Higazi e D. Cines, "REGULATION OF SINGLE-CHAIN UROKINASE BY SMALL PEPTIDES", Thrombosis research, 84(4), 1996, pp. 243-252
86. BEHRENDT N; DANO K
    EFFECT OF PURIFIED, SOLUBLE UROKINASE RECEPTOR ON THE PLASMINOGEN-PROUROKINASE ACTIVATION SYSTEM
    FEBS letters
    
    N. Behrendt e K. Dano, "EFFECT OF PURIFIED, SOLUBLE UROKINASE RECEPTOR ON THE PLASMINOGEN-PROUROKINASE ACTIVATION SYSTEM", FEBS letters, 393(1), 1996, pp. 31-36
87. HIGAZI AAR; MAZAR A; WANG JY; REILLY R; HENKIN J; KNISS D; CINES D
    SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BOUND TO ITS RECEPTOR IS RELATIVELY RESISTANT TO PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1
    Blood
    
    A.A.R. Higazi et al., "SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR BOUND TO ITS RECEPTOR IS RELATIVELY RESISTANT TO PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1", Blood, 87(9), 1996, pp. 3545-3549
88. JIANG YP; PANNELL R; LIU JN; GUREWICH V
    EVIDENCE FOR A NOVEL BINDING-PROTEIN TO UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLATELET MEMBRANES
    Blood
    
    Y.P. Jiang et al., "EVIDENCE FOR A NOVEL BINDING-PROTEIN TO UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLATELET MEMBRANES", Blood, 87(7), 1996, pp. 2775-2781
89. TANAKA K; EINAGA K; TSUCHIYAMA H; TAIT JF; FUJIKAWA K
    PREPARATION AND CHARACTERIZATION OF A DISULFIDE-LINKED BIOCONJUGATE OF ANNEXIN-V WITH THE B-CHAIN OF UROKINASE - AN IMPROVED FIBRINOLYTIC AGENT TARGETED TO PHOSPHOLIPID-CONTAINING THROMBI
    Biochemistry
    
    K. Tanaka et al., "PREPARATION AND CHARACTERIZATION OF A DISULFIDE-LINKED BIOCONJUGATE OF ANNEXIN-V WITH THE B-CHAIN OF UROKINASE - AN IMPROVED FIBRINOLYTIC AGENT TARGETED TO PHOSPHOLIPID-CONTAINING THROMBI", Biochemistry, 35(3), 1996, pp. 922-929
90. CREDO RB; BURKE SE
    FIBRINOLYTIC MECHANISM, BIOCHEMISTRY, AND PRECLINICAL PHARMACOLOGY OFRECOMBINANT PROUROKINASE
    Journal of vascular and interventional radiology
    
    R.B. Credo e S.E. Burke, "FIBRINOLYTIC MECHANISM, BIOCHEMISTRY, AND PRECLINICAL PHARMACOLOGY OFRECOMBINANT PROUROKINASE", Journal of vascular and interventional radiology, 6(6), 1995, pp. 8-18
91. LIJNEN HR; COLLEN D
    MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS
    Bailliere's clinical haematology
    
    H.R. Lijnen e D. Collen, "MECHANISMS OF PHYSIOLOGICAL FIBRINOLYSIS", Bailliere's clinical haematology, 8(2), 1995, pp. 277-290
92. RIJKEN DC
    PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS
    Bailliere's clinical haematology
    
    D.C. Rijken, "PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS", Bailliere's clinical haematology, 8(2), 1995, pp. 291-312
93. NORTHEAST ADR; SOO KS; BOBROW LG; GAFFNEY PJ; BURNAND KG
    THE TISSUE-PLASMINOGEN ACTIVATOR AND UROKINASE RESPONSE IN-VIVO DURING NATURAL RESOLUTION OF VENOUS THROMBUS
    Journal of vascular surgery
    
    A.D.R. Northeast et al., "THE TISSUE-PLASMINOGEN ACTIVATOR AND UROKINASE RESPONSE IN-VIVO DURING NATURAL RESOLUTION OF VENOUS THROMBUS", Journal of vascular surgery, 22(5), 1995, pp. 573-579
94. LENICH C; PANNELL R; GUREWICH V
    ASSEMBLY AND ACTIVATION OF THE INTRINSIC FIBRINOLYTIC PATHWAY ON THE SURFACE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE
    Thrombosis and haemostasis
    
    C. Lenich et al., "ASSEMBLY AND ACTIVATION OF THE INTRINSIC FIBRINOLYTIC PATHWAY ON THE SURFACE OF HUMAN ENDOTHELIAL-CELLS IN CULTURE", Thrombosis and haemostasis, 74(2), 1995, pp. 698-703
95. VANDERKAADEN ME; RIJKEN DC; GROENEVELD E; VANBERKEL TJC; KUIPER J
    NATIVE AND NONGLYCOSYLATED RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE RECOGNIZED BY DIFFERENT RECEPTOR SYSTEMS ON RAT PARENCHYMAL LIVER-CELLS
    Thrombosis and haemostasis
    
    M.E. Vanderkaaden et al., "NATIVE AND NONGLYCOSYLATED RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ARE RECOGNIZED BY DIFFERENT RECEPTOR SYSTEMS ON RAT PARENCHYMAL LIVER-CELLS", Thrombosis and haemostasis, 74(2), 1995, pp. 722-729
96. VERSTRAETE M
    THE FIBRINOLYTIC SYSTEM - FROM PETRI DISHES TO GENETIC-ENGINEERING
    Thrombosis and haemostasis
    
    M. Verstraete, "THE FIBRINOLYTIC SYSTEM - FROM PETRI DISHES TO GENETIC-ENGINEERING", Thrombosis and haemostasis, 74(1), 1995, pp. 25-35
97. LIJNEN HR; COLLEN D
    FIBRINOLYTIC AGENTS - MECHANISMS OF ACTIVITY AND PHARMACOLOGY
    Thrombosis and haemostasis
    
    H.R. Lijnen e D. Collen, "FIBRINOLYTIC AGENTS - MECHANISMS OF ACTIVITY AND PHARMACOLOGY", Thrombosis and haemostasis, 74(1), 1995, pp. 387-390
98. SPANNAGL M; DOOIJEWAARD G; DIETRICH W; KLUFT C
    PROTECTION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) IN APROTININ TREATED CARDIAC SURGICAL PATIENTS UNDERGOING CARDIOPULMONARY BYPASS
    Thrombosis and haemostasis
    
    M. Spannagl et al., "PROTECTION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (SCU-PA) IN APROTININ TREATED CARDIAC SURGICAL PATIENTS UNDERGOING CARDIOPULMONARY BYPASS", Thrombosis and haemostasis, 73(5), 1995, pp. 825-828
99. BASHKOV GV; JITKOVA JV
    A COMBINATION OF RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE HAS A SYNERGISTIC NON-FIBRIN SPECIFIC ACTION ON IN-VITRO CLOT LYSIS
    Fibrinolysis
    
    G.V. Bashkov e J.V. Jitkova, "A COMBINATION OF RECOMBINANT SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE HAS A SYNERGISTIC NON-FIBRIN SPECIFIC ACTION ON IN-VITRO CLOT LYSIS", Fibrinolysis, 9(6), 1995, pp. 356-362
100. GUREWICH V; PANNELL R; LIU JN
     UNTITLED
     Fibrinolysis
     
     V. Gurewich et al., "UNTITLED", Fibrinolysis, 9(4), 1995, pp. 259-260